Literature DB >> 17396993

The probable source of both the primary multidrug-resistant (MDR) HIV-1 strain found in a patient with rapid progression to AIDS and a second recombinant MDR strain found in a chronically HIV-1-infected patient.

Gary Blick1, Ron M Kagan, Eoin Coakley, Christos Petropoulos, Laura Maroldo, Paola Greiger-Zanlungo, Scott Gretz, Trish Garton.   

Abstract

BACKGROUND: Rapid progression to AIDS after acute infection with a multidrug-resistant (MDR), dual-tropic strain of human immunodeficiency virus type 1 (HIV-1) was reported in a New York City man (hereafter referred to as "NYC") who has sex with men. The probable source of this HIV-1 (hereafter referred to as "CT01") and the development of a recombinant MDR HIV-1 in the source's partner (hereafter referred to as "CT02") are described.
METHODS: After identification of the epidemiological link of CT01 and CT02 to NYC, viral sequences and phenotypic analyses were compared. Confirmatory genotypic and phenotypic analyses, replicative capacity, and viral coreceptor use were assessed. Viral recombination was assessed using a sliding window technique and phylogenetic tree analysis.
RESULTS: NYC and CT01 were linked historically and epidemiologically and were genetically confirmed from CT01's samples acquired 2 days before and subsequent to the transmission event. Genotypic, recombination, and phylogenetic analyses suggest CT02 became superinfected by CT01 with subsequent production of a recombinant panresistant HIV-1.
CONCLUSION: The probable source of a dual-tropic, MDR HIV-1 that was associated with rapid progression to AIDS is illustrated, suggesting progression was not explained by the HIV-1 variant alone. A probable second finding of a chronically infected host becoming superinfected with MDR HIV-1 with subsequent formation of a panresistant recombinant HIV-1 is described. This case illustrates the public health implications of unsafe sex between serodiscordant and seroconcordant partners.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396993     DOI: 10.1086/512240

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

1.  Recombination between variants from genital tract and plasma: evolution of multidrug-resistant HIV type 1.

Authors:  Kimdar S Kemal; Christina M Ramirez; Harold Burger; Brian Foley; Douglas Mayers; Thomas Klimkait; François Hamy; Kathryn Anastos; Katarina Petrovic; Vladimir N Minin; Marc A Suchard; Barbara Weiser
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-10       Impact factor: 2.205

2.  Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses.

Authors:  Colleen S Kraft; Debby Basu; Paulina A Hawkins; Peter T Hraber; Elwyn Chomba; Joseph Mulenga; William Kilembe; Naw H Khu; Cynthia A Derdeyn; Susan A Allen; Olivier Manigart; Eric Hunter
Journal:  Retrovirology       Date:  2012-03-20       Impact factor: 4.602

3.  Characterization of the Neutralizing Antibody Response in a Case of Genetically Linked HIV Superinfection.

Authors:  Deogratius Ssemwanga; Nicole A Doria-Rose; Andrew D Redd; Andrea R Shiakolas; Andrew F Longosz; Rebecca N Nsubuga; Billy N Mayanja; Gershim Asiki; Janet Seeley; Anatoli Kamali; Amy Ransier; Samuel Darko; Michael P Walker; Daniel Bruno; Craig Martens; Daniel Douek; Stephen F Porcella; Thomas C Quinn; John R Mascola; Pontiano Kaleebu
Journal:  J Infect Dis       Date:  2018-04-23       Impact factor: 5.226

4.  Evaluation of the impact of news coverage of an HIV multiclass drug-resistant cluster in Seattle, Washington.

Authors:  Erin M Kahle; Elizabeth A Barash; Libby C Page; Amy Lansky; Krishna Jafa; Patrick S Sullivan; Susan E Buskin
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

5.  Implementation of HIV testing at 2 New York City bathhouses: from pilot to clinical service.

Authors:  Demetre Daskalakis; Richard Silvera; Kyle Bernstein; Dylan Stein; Robert Hagerty; Richard Hutt; Alith Maillard; William Borkowsky; Judith Aberg; Fred Valentine; Michael Marmor
Journal:  Clin Infect Dis       Date:  2009-06-01       Impact factor: 9.079

6.  Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.

Authors:  Wendy W Yeh; Pimkwan Jaru-Ampornpan; Daiva Nevidomskyte; Mohammed Asmal; Srinivas S Rao; Adam P Buzby; David C Montefiori; Bette T Korber; Norman L Letvin
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

7.  The efficacy of T cell-mediated immune responses is reduced by the envelope protein of the chimeric HIV-1/SIV-KB9 virus in vivo.

Authors:  Liljana Stevceva; Victor Yoon; Angela Carville; Beatriz Pacheco; Michael Santosuosso; Birgit Korioth-Schmitz; Keith Mansfield; Mark C Poznansky
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

8.  Influence of social changes on the evolution of HIV infection in Romania.

Authors:  Simona Rutã; Costin Cernescu
Journal:  Int J Environ Stud       Date:  2008

9.  Framing Samuel See: the discursive detritus of the moral panic over the "double epidemic" of methamphetamines and HIV among gay men.

Authors:  Theodore K Gideonse
Journal:  Int J Drug Policy       Date:  2015-12-11

10.  Transmitted antiretroviral drug resistance in New York State, 2006-2008: results from a new surveillance system.

Authors:  Adam C Readhead; Daniel E Gordon; Zhengyan Wang; Bridget J Anderson; Kathleen S Brousseau; Maria A Kouznetsova; Lisa A Forgione; Lou C Smith; Lucia V Torian
Journal:  PLoS One       Date:  2012-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.